The Epidemiology of Pulmonary Nontuberculous Mycobacteria: Data from a General Hospital in Athens, Greece, 2007–2013
Table 1
(a) Study population; demographic characteristics (120 Patients). (b) Study population; clinical Characteristics (74 patients).
(a)
Gender
Females
76 (63%)
Males
44 (37%)
Total age (years)
69.9 ± 15.4
Age group
<20 years
0 (0%)
20–40 years
10 (8%)
40–60 years
12 (10%)
>60 years
98 (82%)
Ethnicity
Greek
110 (92%)
Others (including Middle East, East Europe, and Balkans)
10 (8%)
Residence
Greece
120 (100%)
(b)
All
Colonized ()
Diseased ()
value
Chronic lung disease
COPD
32 (43%)
26 (42%)
6 (50%)
0.606
Bronchiectasis
25 (33%)
22 (35%)
3 (25%)
0.635
Asthma
5 (6%)
4 (6.4%)
1 (8.3%)
0.892
Cystic fibrosis
1 (1.3%)
1 (1.6%)
0 (0%)
0.683
Old TB
13 (17%)
8 (13%)
5 (41%)
0.030
Use of CS
Inhaled CS
23 (32%)
20 (32%)
3 (25%)
0.528
Systemic CS
10 (14%)
10 (16%)
0 (0%)
0.140
Smoking habit
Current or ex-smokers
44 (59%)
37 (59%)
7 (58%)
0.221
Never being smokers
30 (41%)
25 (40%)
5 (42%)
0.223
Others
HIV
0
0
0
N/A
Autoimmune disease
1 (1.3%)
1 (1.6%)
0 (0%)
0.683
Data are presented as mean ± standard deviation (SD) for numerical variables or as number (%) for categorical variables. COPD: chronic obstructive pulmonary disease, HIV: human immunodeficiency virus, and CS: corticosteroid.
